160 related articles for article (PubMed ID: 24346344)
1. Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer model.
Nicastro HL; Grubbs CJ; Margaret Juliana M; Bode AM; Kim MS; Lu Y; You M; Milne GL; Boring D; Steele VE; Lubet RA
Cancer Prev Res (Phila); 2014 Feb; 7(2):246-54. PubMed ID: 24346344
[TBL] [Abstract][Full Text] [Related]
2. Re: Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer model.
Chang SS
J Urol; 2015 May; 193(5):1727. PubMed ID: 25895810
[No Abstract] [Full Text] [Related]
3. Prevention of chemically induced urinary bladder cancers by naproxen: protocols to reduce gastric toxicity in humans do not alter preventive efficacy.
Lubet RA; Scheiman JM; Bode A; White J; Minasian L; Juliana MM; Boring DL; Steele VE; Grubbs CJ
Cancer Prev Res (Phila); 2015 Apr; 8(4):296-302. PubMed ID: 25762530
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive efficacy of naproxen and nitric oxide-naproxen in rodent models of colon, urinary bladder, and mammary cancers.
Steele VE; Rao CV; Zhang Y; Patlolla J; Boring D; Kopelovich L; Juliana MM; Grubbs CJ; Lubet RA
Cancer Prev Res (Phila); 2009 Nov; 2(11):951-6. PubMed ID: 19892664
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory action of alpha-difluoromethylornithine on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis.
Uchida K; Seidenfeld J; Rademaker A; Oyasu R
Cancer Res; 1989 Oct; 49(19):5249-53. PubMed ID: 2504487
[TBL] [Abstract][Full Text] [Related]
6. Screening agents for preventive efficacy in a bladder cancer model: study design, end points, and gefitinib and naproxen efficacy.
Lubet RA; Steele VE; Juliana MM; Grubbs CJ
J Urol; 2010 Apr; 183(4):1598-603. PubMed ID: 20172542
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of OH-BBN-induced bladder cancer in mice by oltipraz, alone and in combination with 4-HPR and DFMO.
Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC
Anticancer Res; 1994; 14(1A):5-11. PubMed ID: 8166455
[TBL] [Abstract][Full Text] [Related]
8. Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder.
Rao KV; Detrisac CJ; Steele VE; Hawk ET; Kelloff GJ; McCormick DL
Carcinogenesis; 1996 Jul; 17(7):1435-8. PubMed ID: 8706245
[TBL] [Abstract][Full Text] [Related]
9. 4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin.
Lubet RA; Huebner K; Fong LY; Altieri DC; Steele VE; Kopelovich L; Kavanaugh C; Juliana MM; Soong SJ; Grubbs CJ
Carcinogenesis; 2005 Mar; 26(3):571-8. PubMed ID: 15591090
[TBL] [Abstract][Full Text] [Related]
10. Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers.
Mohammed A; Miller MS; Lubet RA; Suen CS; Sei S; Shoemaker RH; Juliana MM; Moeinpour FL; Grubbs CJ
Cancer Prev Res (Phila); 2020 Mar; 13(3):273-282. PubMed ID: 31818850
[TBL] [Abstract][Full Text] [Related]
11. Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats.
Suh N; Reddy BS; DeCastro A; Paul S; Lee HJ; Smolarek AK; So JY; Simi B; Wang CX; Janakiram NB; Steele V; Rao CV
Cancer Prev Res (Phila); 2011 Nov; 4(11):1895-902. PubMed ID: 21764859
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis by alpha-difluoromethylornithine.
Homma Y; Kakizoe T; Samma S; Oyasu R
Cancer Res; 1987 Dec; 47(23):6176-9. PubMed ID: 3119193
[TBL] [Abstract][Full Text] [Related]
13. Interspecies analysis of the chemopreventive efficacy of dietary alpha-difluoromethylornithine.
Ratko TA; Detrisac CJ; Rao KV; Thomas CF; Kelloff GJ; Moon RC
Anticancer Res; 1990; 10(1):67-72. PubMed ID: 2110434
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet.
Reddy BS; Nayini J; Tokumo K; Rigotty J; Zang E; Kelloff G
Cancer Res; 1990 May; 50(9):2562-8. PubMed ID: 2109653
[TBL] [Abstract][Full Text] [Related]
15. Chemopreventive efficacy of Targretin in rodent models of urinary bladder, colon/intestine, head and neck and mammary cancers.
Lubet RA; Clapper ML; McCormick DL; Pereira MA; Chang WC; Steele VE; Fischer SM; Juliana MM; Grubbs CJ
Oncol Rep; 2012 May; 27(5):1400-6. PubMed ID: 22307264
[TBL] [Abstract][Full Text] [Related]
16. Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine.
Lawson KR; Ignatenko NA; Piazza GA; Cui H; Gerner EW
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1155-62. PubMed ID: 11097222
[TBL] [Abstract][Full Text] [Related]
17. Suppression of rat urinary bladder carcinogenesis by alpha-difluoromethylornithine.
Homma Y; Kakizoe T; Samma S; Oyasu R
J Urol; 1989 Jun; 141(6):1454-7. PubMed ID: 2498534
[TBL] [Abstract][Full Text] [Related]
18. Combination chemoprevention of intestinal carcinogenesis in a murine model of familial adenomatous polyposis.
Ignatenko NA; Besselsen DG; Stringer DE; Blohm-Mangone KA; Cui H; Gerner EW
Nutr Cancer; 2008; 60 Suppl 1():30-5. PubMed ID: 19003578
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
20. Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Nakanishi K; Hagiwara A; Shibata M; Imaida K; Tatematsu M; Ito N
J Natl Cancer Inst; 1980 Nov; 65(5):1005-10. PubMed ID: 6933236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
